By proceeding, you agree to our Terms of Use and Privacy Policy.
Chief Scientific Officer
#rarediseases #eeg
#NorthAmerica
Cross-Functional Drug Discovery and Development Program and Team Leader with 20 years of discovery, preclinical, clinical and biopharma management experience in biotech startups through global pharma.
Chief Executive Officer
#Europe
Klaus is currently CEO of Vandria and a Board member at AOBiome Therapeutics and Ferring Ventures. Klaus was a PostDoc for four years at the National Institutes of Health in Bethesda, US, conducting r